Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective

被引：43

作者：

Fallica, Antonino N. ^{[1
]}

Pittala, Valeria ^{[1
]}

Modica, Maria N. ^{[1
]}

Salerno, Loredana ^{[1
]}

Romeo, Giuseppe ^{[1
]}

Marrazzo, Agostino ^{[1
]}

Helal, Mohamed A. ^{[2
,3
]}

Intagliata, Sebastiano ^{[1
]}

机构：

[1] Univ Catania, Dept Drug & Hlth Sci, I-95125 Catania, Italy

[2] Univ Sci & Technol, Biomed Sci Program, Zewail City Sci & Technol, Giza 12578, Egypt

[3] Suez Canal Univ, Fac Pharm, Med Chem Dept, Ismailia 41522, Egypt

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2021年 / 64卷 / 12期

关键词：

TUMOR-CELL DEATH; HIGH-AFFINITY; IN-VITRO; BINDING-SITE; BIOLOGICAL EVALUATION; PHARMACOPHORE MODEL; HIGHLY POTENT; PHARMACOLOGICAL EVALUATION; ENDOPLASMIC-RETICULUM; SUBNANOMOLAR AFFINITY;

D O I：

10.1021/acs.jmedchem.0c02265

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Since their discovery as distinct receptor proteins, the specific physiopathological role of sigma receptors (sigma Rs) has been deeply investigated. It has been reported that these proteins, classified into two subtypes indicated as sigma(1) and sigma(2), might play a pivotal role in cancer growth, cell proliferation, and tumor aggressiveness. As a result, the development of selective sigma R ligands with potential antitumor properties attracted significant attention as an emerging theme in cancer research. This perspective deals with the recent advances of sigma R ligands as novel cytotoxic agents, covering articles published between 2010 and 2020. An up-to-date description of the medicinal chemistry of selective sigma R-1 and sigma R-2 ligands with antiproliferative and cytotoxic activities has been provided, including major pharmacophore models and comprehensive structure-activity relationships for each main class of sigma R ligands.

引用

页码：7926 / 7962

页数：37

共 50 条

[31] Recent Advances in the Medicinal Chemistry of Histone Deacetylase Inhibitors
Brittain, Dominic
Weinmann, Hilmar
Ottow, Eckhard
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42, 2007, 42 : 337 - 348
[32] Recent advances in medicinal chemistry of oleanolic acid derivatives
Yang, Yi-Hui
Dai, Si-Yang
Deng, Fu-Hua
Peng, Li-Huan
Li, Chang
Pei, Yue-Hu
PHYTOCHEMISTRY, 2022, 203
[33] Recent Advances in Medicinal Chemistry and Chemical Biology Preface
Garbaccio, Robert M.
Johnson, Douglas S.
Hong, Jiyong
Disney, Matthew D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4714 - 4714
[34] Recent advances in medicinal chemistry of histone deacetylase inhibitors
Weinmann, H
Ottow, E
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 39, 2004, 39 : 185 - 196
[35] Recent Advances in the Synthesis of Tamoxifen and Analogues in Medicinal Chemistry
Tandon, Nitin
Luxami, Vijay
Tandon, Runjhun
Paul, Kamaldeep
ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2020, 9 (10) : 1432 - 1465
[36] Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis
Srivastava, Santosh K.
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (14) : 1189 - 1190
[37] Recent advances in the synthesis and medicinal perspective of pyrazole-based α-amylase inhibitors as antidiabetic agents
Khator, Rakesh
Monga, Vikramdeep
FUTURE MEDICINAL CHEMISTRY, 2024, 16 (02)
[38] DEVELOPMENT OF RADIOSENSITIZERS - A MEDICINAL CHEMISTRY PERSPECTIVE
NARAYANAN, VL
LEE, WW
ADVANCES IN PHARMACOLOGY AND CHEMOTHERAPY, 1982, 19 : 155 - 205
[39] Recent advances in the chemistry and biology of antimycobacterial agents
Baker, WR
Mitscher, LA
Arain, TM
Shawar, R
Stover, CK
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 31, 1996, 31 : 161 - 170
[40] Recent advances in the synthetic and medicinal perspective of quinolones: A review
Dhiman, Prashant
Arora, Nidhi
Thanikachalam, Punniyakoti Veeraveedu
Monga, Vikramdeep
BIOORGANIC CHEMISTRY, 2019, 92

← 1 2 3 4 5 →